These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4159547)

  • 1. [Trial of a synthetic heparinoid in the treatment of atherogenic dyslipemia].
    Broustet P; Dallocchio M; Crockett R; Bricaud H
    Gaz Med Fr; 1965 Oct; 72(20):3513-7. PubMed ID: 4159547
    [No Abstract]   [Full Text] [Related]  

  • 2. [Atherogenic dislipemias and heparinoid].
    Romero RL; Maljar L; Marchetti B; Rufino W; Cacciatore J
    Prensa Med Argent; 1965 Sep; 52(34):1962-6. PubMed ID: 4158854
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hyperlipemia: clinico-therapeutic experience with a heparinoid].
    De Martino G; D'Aniello L; De Simone E; Belli MG; Buonfantino M
    Clin Ter; 1978 Sep; 86(6):583-95. PubMed ID: 83925
    [No Abstract]   [Full Text] [Related]  

  • 4. [Heparinoids in the treatment of dyslipemia in patients with diabetic vasculopathy: action of 3gs].
    Cavazzini MG
    Clin Ter; 1978 Jan; 84(1):41-64. PubMed ID: 75777
    [No Abstract]   [Full Text] [Related]  

  • 5. [On hypocholesterolemizing activity of 1-phenyl-1-hydroxy-N-pentane associated with a duodenal heparinoid].
    Coscelli C; Rizzoli V
    Clin Ter; 1965 Jul; 34(2):122-30. PubMed ID: 4158353
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biological efficacy of a treatment by a semisynthetic heparinoid. Apropos of approximately 100 cases].
    Thiercelin PC; Saint-Blancard J; Raby C
    Ann Biol Clin (Paris); 1965; 23(7):883-94. PubMed ID: 4158605
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of therapy with heparinoid extracts on arteriosclerosis in the inner ear].
    Sperati G
    Minerva Otorinolaringol; 1969; 19(5):281-4. PubMed ID: 4191379
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical effects, therapeutic indications and posology of synthetic heparinoid 8.061 CB].
    Bourgeois S; Noel B
    Phlebologie; 1967; 20(3):321-8. PubMed ID: 4168153
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sodium iodoheparinate in the treatment of atherosclerosis and dyslipemia. Apropos of 40 cases].
    Desruelles J; Decalf A; Delcourt P; Waucampt JJ
    Lille Med; 1965; 10(6):666-70. PubMed ID: 5834773
    [No Abstract]   [Full Text] [Related]  

  • 10. [Modifications of platelet adhesiveness and aggregation ability in atherosclerotics treated with a polysulfoester of pentosan (SP-54). II].
    Cajozzo A; Citarrella P; Carreca I
    Boll Soc Ital Cardiol; 1971; 16(3):127-34. PubMed ID: 4110181
    [No Abstract]   [Full Text] [Related]  

  • 11. [New heparinoid extract in the treatment of arterial diseases of the lower limb].
    Caramelli L; Spinelli P
    Clin Ter; 1975 Oct; 75(1):43-63. PubMed ID: 58752
    [No Abstract]   [Full Text] [Related]  

  • 12. [Atheroma and synthetic heparinoids].
    Lekiefre J; Ougier J
    Lille Med; 1966; 11(6):726-9. PubMed ID: 4161337
    [No Abstract]   [Full Text] [Related]  

  • 13. [8061 CB, a synthetic heparinoid and the prevention of thrombo-embolic complications].
    Lucchesi R
    Cah Anesthesiol; 1968; 16(1):63-73. PubMed ID: 4191495
    [No Abstract]   [Full Text] [Related]  

  • 14. [Controlled clinical trial of a topical heparin- and heparinoid- based cream in the treatment of vascular diseases].
    Ghiringhelli L
    Boll Chim Farm; 1984 Apr; 123(4):42S-46S. PubMed ID: 6206879
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevention and treatment of thrombosis by a synthetic heparinoid: indications in the obstetrical field].
    Baron F; Jahier J; Leclerc F; Chatelain P; Pelikan P; Gauliard M
    Lyon Med; 1969 Sep; 222(31):239-42 passim. PubMed ID: 4098609
    [No Abstract]   [Full Text] [Related]  

  • 16. [Activity of glucuronyl-glucosamine-glycan sulfate in patients with dyslipemia. Medium-term study].
    Pedrazzi F; Bonazzi L; Peterlin F
    Clin Ter; 1975 May; 73(4):327-42. PubMed ID: 1240795
    [No Abstract]   [Full Text] [Related]  

  • 17. [Attempts of treatment of peripheral blood circulation disorders including thromboembolic and hyperlipemic conditions with pentosanpolysulfoester (PPE)].
    Szirmai E; Celander DR
    Pharmazie; 1968 Sep; 23(9):501-2. PubMed ID: 4180427
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of diseases due to varices with a natural heparinoid].
    Resta V; Dei Rossi C
    Minerva Med; 1966 Jan; 57(3):49-55. PubMed ID: 4159337
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effects of oral administration of a sulfo-polysaccharide of low molecular weight in a group of sedentary workers with ateriosclerotic cardiovascular disease].
    Alessandri M; Fiorentini P; Garagnani C
    G Clin Med; 1967 Sep; 48(9):935-47. PubMed ID: 4180085
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral lichen planus: clinical and histological evaluation in an open trial using a low molecular weight heparinoid (sulodexide).
    Femiano F; Scully C
    Int J Dermatol; 2006 Aug; 45(8):986-9. PubMed ID: 16911394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.